tenofovir has been researched along with sybr green i in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chemin, I; Diop, M; Ghosh, S; Guillot, C; Jeng, A; Kane, CT; Lemoine, M; Mboup, S; Mendy, M; Ndow, G; Njie, R; Sow, A; Thursz, M; Toure, S; Zoulim, F | 1 |
1 other study(ies) available for tenofovir and sybr green i
Article | Year |
---|---|
Implementation of an in-house quantitative real-time polymerase chain reaction method for Hepatitis B virus quantification in West African countries.
Topics: Antiviral Agents; Benzothiazoles; Costs and Cost Analysis; Diamines; DNA Primers; DNA, Viral; Drug Monitoring; Follow-Up Studies; Gambia; Hepatitis B virus; Hepatitis B, Chronic; Humans; Organic Chemicals; Quinolines; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Senegal; Sensitivity and Specificity; Staining and Labeling; Tenofovir; Time Factors; Viral Load | 2016 |